ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3016 - 3030 of 5662 products
WuXi AppTec to Acquire Texas-Based Global Clinical Trial CRO
$5.00
Available
Chi-Med/AstraZeneca Drug Shows Efficacy Against Lung Cancer
$5.00
Available
Shenzhen Hepalink Invests $69 Million in Canada's Resverlogix
$5.00
Available
Huawei and Phillips Building AI Healthcare Platform for China
$5.00
Available
CASI Pharma Raises $23 Million in Private Placement
$5.00
Available
Innovent Licenses Use of Harbour Biomed's Biologic Drug Discovery Platform
$5.00
Available
China Biologic to Acquire TianXinFu, a Device Company, in $536 Million Deal
$5.00
Available
Samsung BioLogics' New Plant Approved by FDA
$5.00
Available
Generon Announces SPA for US Phase III Trial of Neutropenia Drug
$5.00
Available
Gentris and Shanghai Institute Sign MOU for Biomarker Collaboration
$5.00
Available
China's State Council Endorses CFDA's New Foreign Clinical Trial Data Policies
$5.00
Available
Shanghai Pharma in Second Round Bidding in $1.5 Billion Cardinal China Deal
$5.00
Available
Beijing is Home to Gates-Backed $100 Million Global Health Institute
$5.00
Available
Zhejiang Huahai Raises $152 Million for New Biopharma Facility
$5.00
Available
Hong Kong's Jacobson Pharma Raises $64 Million for M&A
$5.00
Available